Commercial interests, transparency, and independence: a call for submissions

Ray Moynihan, Helen Macdonald, Carl Heneghan, Lisa Bero, Fiona Godlee

Research output: Contribution to journalEditorialResearch

Abstract

[Extract] Help the move towards independence from commercial interests

A decade ago the US Institute of Medicine (IOM) issued a landmark report on conflicts of interest in research, medical education, and practice.1 Highlighting benefits of collaborations between physicians, researchers, and companies to develop new products that can improve health, the report also raised substantial concerns that extensive financial ties could unduly influence professional judgments. It concluded these financial conflicts of interest could jeopardise the integrity of science, the objectivity of education, the quality of care, and public trust in medicine. The report recommended more research on conflicts of interest, improvements in transparency, and greater independence from industry.

Today we announce plans for a stream of BMJ content to revisit these concerns and ask you to join us. A key aim is to identify and respond to commercial influences on health and healthcare, to understand under what circumstances involvement with industry is truly necessary. Where it is not necessary, we want to forge a new independence from those who make and sell products, to strengthen trust in how evidence is produced and disseminated, and to drive more rational and safer use of drugs, devices, diagnoses, and data in the public interest.
LanguageEnglish
Article numberl1706
JournalBMJ (Online)
Volume365
DOIs
Publication statusPublished - 16 Apr 2019

Fingerprint

Conflict of Interest
Industry
Occupational Health Physicians
National Academies of Science, Engineering, and Medicine (U.S.) Health and Medicine Division
Quality of Health Care
Health
Medical Education
Research
Research Personnel
Medicine
Delivery of Health Care
Education
Equipment and Supplies
Pharmaceutical Preparations

Cite this

Moynihan, Ray ; Macdonald, Helen ; Heneghan, Carl ; Bero, Lisa ; Godlee, Fiona. / Commercial interests, transparency, and independence : a call for submissions. In: BMJ (Online). 2019 ; Vol. 365.
@article{091301a79d56402bad2dae6ee4dd4d1b,
title = "Commercial interests, transparency, and independence: a call for submissions",
abstract = "[Extract] Help the move towards independence from commercial interestsA decade ago the US Institute of Medicine (IOM) issued a landmark report on conflicts of interest in research, medical education, and practice.1 Highlighting benefits of collaborations between physicians, researchers, and companies to develop new products that can improve health, the report also raised substantial concerns that extensive financial ties could unduly influence professional judgments. It concluded these financial conflicts of interest could jeopardise the integrity of science, the objectivity of education, the quality of care, and public trust in medicine. The report recommended more research on conflicts of interest, improvements in transparency, and greater independence from industry.Today we announce plans for a stream of BMJ content to revisit these concerns and ask you to join us. A key aim is to identify and respond to commercial influences on health and healthcare, to understand under what circumstances involvement with industry is truly necessary. Where it is not necessary, we want to forge a new independence from those who make and sell products, to strengthen trust in how evidence is produced and disseminated, and to drive more rational and safer use of drugs, devices, diagnoses, and data in the public interest.",
author = "Ray Moynihan and Helen Macdonald and Carl Heneghan and Lisa Bero and Fiona Godlee",
year = "2019",
month = "4",
day = "16",
doi = "10.1136/bmj.l1706",
language = "English",
volume = "365",
journal = "BMJ (Clinical research ed.)",
issn = "0959-535X",
publisher = "BMJ Publishing Group",

}

Commercial interests, transparency, and independence : a call for submissions. / Moynihan, Ray; Macdonald, Helen; Heneghan, Carl; Bero, Lisa; Godlee, Fiona.

In: BMJ (Online), Vol. 365, l1706, 16.04.2019.

Research output: Contribution to journalEditorialResearch

TY - JOUR

T1 - Commercial interests, transparency, and independence

T2 - BMJ (Clinical research ed.)

AU - Moynihan, Ray

AU - Macdonald, Helen

AU - Heneghan, Carl

AU - Bero, Lisa

AU - Godlee, Fiona

PY - 2019/4/16

Y1 - 2019/4/16

N2 - [Extract] Help the move towards independence from commercial interestsA decade ago the US Institute of Medicine (IOM) issued a landmark report on conflicts of interest in research, medical education, and practice.1 Highlighting benefits of collaborations between physicians, researchers, and companies to develop new products that can improve health, the report also raised substantial concerns that extensive financial ties could unduly influence professional judgments. It concluded these financial conflicts of interest could jeopardise the integrity of science, the objectivity of education, the quality of care, and public trust in medicine. The report recommended more research on conflicts of interest, improvements in transparency, and greater independence from industry.Today we announce plans for a stream of BMJ content to revisit these concerns and ask you to join us. A key aim is to identify and respond to commercial influences on health and healthcare, to understand under what circumstances involvement with industry is truly necessary. Where it is not necessary, we want to forge a new independence from those who make and sell products, to strengthen trust in how evidence is produced and disseminated, and to drive more rational and safer use of drugs, devices, diagnoses, and data in the public interest.

AB - [Extract] Help the move towards independence from commercial interestsA decade ago the US Institute of Medicine (IOM) issued a landmark report on conflicts of interest in research, medical education, and practice.1 Highlighting benefits of collaborations between physicians, researchers, and companies to develop new products that can improve health, the report also raised substantial concerns that extensive financial ties could unduly influence professional judgments. It concluded these financial conflicts of interest could jeopardise the integrity of science, the objectivity of education, the quality of care, and public trust in medicine. The report recommended more research on conflicts of interest, improvements in transparency, and greater independence from industry.Today we announce plans for a stream of BMJ content to revisit these concerns and ask you to join us. A key aim is to identify and respond to commercial influences on health and healthcare, to understand under what circumstances involvement with industry is truly necessary. Where it is not necessary, we want to forge a new independence from those who make and sell products, to strengthen trust in how evidence is produced and disseminated, and to drive more rational and safer use of drugs, devices, diagnoses, and data in the public interest.

UR - http://www.scopus.com/inward/record.url?scp=85064993704&partnerID=8YFLogxK

U2 - 10.1136/bmj.l1706

DO - 10.1136/bmj.l1706

M3 - Editorial

VL - 365

JO - BMJ (Clinical research ed.)

JF - BMJ (Clinical research ed.)

SN - 0959-535X

M1 - l1706

ER -